Neutrophil-to-lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
Toshifumi TadaTakashi KumadaAtsushi HiraokaKojiro MichitakaMasanori AtsukawaMasashi HirookaKunihiko TsujiToru IshikawaKoichi TakaguchiKazuya KariyamaEi ItobayashiKazuto TajiriNoritomo ShimadaHiroshi ShibataHironori OchiSatoshi YasudaHidenori ToyodaShinya FukunishiHideko OhamaKazuhito KawataShinichiro NakamuraKazuhiro NousoAkemi TsutsuiTakuya NaganoNorio ItokawaKorenobu HayamaTaeang AraiMichitaka ImaiKouji JokoYohei KoizumiYoichi HiasaPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
NLR can be associated with outcomes in patients with HCC treated with lenvatinib.